(AOF) – Spineguard announces that its consolidated turnover is down 30% in the fourth quarter of 2023 compared to the fourth quarter of 2022 at 1.10 million euros, and by 23% over the entire financial year at 4.31 million euros. The company specializing in real-time surgical guidance for the placement of bone implants adds that its cash position as of December 31, 2023 amounts to €3.9 million, so it now has a horizon of cash flow until 2025.
In the United States, fourth-quarter revenue fell 28% in dollars to $734,000 due to the cessation of the activity of WishBone Medical, which had the exclusive distribution of SpineGuard products in American pediatric orthopedic hospitals. .
In the rest of the world, sales increased by 11% for products in the fourth quarter and by 22% for the whole year, marked by good growth in Europe as well as in Latin America, and includes a large order in China.
© 2024 Agence Option Finance (AOF) – All reproduction rights reserved by AOF. AOF collects its data from the sources it considers the safest. However, the reader remains solely responsible for their interpretation and use of the information made available to them. The reader must therefore hold AOF and its contributors harmless from any claim resulting from this use. Agence Option Finance (AOF) is a brand of the Option Finance group
Did you like this article ? Share it with your friends using the buttons below.
